2010 CBD S&T Conference
Conference Proceedings
Photo Gallery
CBD S&T Administrative Conference Organizer
Strategic Analysis, Inc.
cbdstconf09@sainc.com
http://www.dtra.mil/
WEDNESDAY, 18 NOVEMBER 2009
| Session: Pathogen-directed Therapeutics | |
| Chair: Joseph Larsen | |
| 1400 - 1430 | Jennifer Brannan, USAMRIID |
| Potential Ebola Therapies Identified Using HighThroughput Phenotypic Screening of Drugs and Combinations | |
| 1430 - 1500 | Stanley Goldman, Genetic Chemistry, Inc. |
| Using Watchmaker® Technology to Discover and Evolve Novel Small Molecule Antibiotics | |
| 1500 - 1530 | Michael Gwynn, GlaxoSmithKline |
| A Novel Broad Spectrum Class of Antibacterials for Nosocomial and Biothreat Pathogens | |
| 1530 - 1600 | Break |
| 1600 - 1630 | Anders Wallqvist, BHSAI |
| Rational Drug Design using Docking-Based Virtual Screening (DOVIS) | |
| 1630 - 1700 | Rekha Panchal, USAMRIID |
| High content bioimaging platform for drug discovery and dissection of the host-pathogen interactions | |
| 1700 - 1730 | Arthur Goff, The United States Army Medical Research Institute for Infectious Diseases |
| A Double Blind, Randomized, Placebo-Controlled, Repeat-Dose Efficacy Study of the Primate equivalent of the proposed Human Dose (400 Mg/Day) of Oral ST-246® in Cynomolgus Monkeys Infected with Monkeypox Virus | |
| Return to previous page | |